North America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022125 | No. of Pages: 195 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The In-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027.

Chronic diseases prominently include cancers, chronic respiratory diseases, diabetes, and heart disease. These conditions are accelerating due to biological risk factors, increase in alcoholism, unhealthy diet, physical inactivity, tobacco consumption, and obesity. Chronic conditions are the leading cause of mortality. For instance, according to a study published by American Heart Association, Inc., in 2016, cardiovascular diseases (CVDs) were responsible for the loss of an estimated 0.84 million population in the US. Moreover, according to the studies, CVDs and stroke accounted for an estimated 14.0% of total healthcare expenditure in the US, creating a massive impact of overall healthcare spending. Along with cardiovascular conditions, a higher prevalence of other conditions, such as diabetes, cancer, and obesity, is equally anticipated to boost the growth of the global in-vitro diagnostics market during the forecast period. For instance, according to data published by the Centers for Disease Control and Prevention, in 2019, approximately 30 million people in the US had diabetes. Moreover, according to the estimates, diabetes in the 7th leading cause of mortality in the US. Certain factors, such as overweight conditions, genetic conditions, aging, and sedentary lifestyle, are further anticipated to boost the prevalence of diabetes in the region. Hence, rising incidence of infectious and chronic diseases, such as cardiovascular diseases, cancer, diabetes, and respiratory conditions, are projected to drive the global in-vitro diagnostics market during the forecast period.

 

The outbreak of COVID-19 has offered significant growth opportunities for the in-vitro diagnostics market in the North American region. The US was likely adversely affected by the pandemic and faced significant mortalities due to SARS-CoV-2 virus infection. Hence, to detect the presence of infection among the people, there was a huge demand generated for in vitro diagnostics and rapid tests. The generated demand has offered positive growth for the in-vitro diagnostic market in the region. In addition, various companies have shifted their focus to molecular diagnostics and testing. Thus, there was an exponential shift in demand for RT-PCR procedures, assays, kits, and reagents, as these diagnostic technologies offer results in less time. Also, the companies operating in this particular segment (IVD) have generated profits.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The North America In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.


Get more information on this report :

North America In-Vitro Diagnostics Market Segmentation        

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • North America
    • US
    • Canada
    • Mexico

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        In-Vitro Diagnostics Market – By Product and Services

1.3.2        In-Vitro Diagnostics Market – By Technology

1.3.3        In-Vitro Diagnostics Market – By Application

1.3.4        In-Vitro Diagnostics Market – By End User

1.3.5        North America In-Vitro Diagnostics Market – By Country

2.           North America In-Vitro Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America In-Vitro Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        In-Vitro Diagnostics Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America In-Vitro Diagnostics Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Chronic and Infectious Diseases

5.1.2        Growing Geriatric Population

5.1.3        Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic

5.2         Market Restraints

5.2.1        Lack of Healthcare Infrastructure and Reimbursement Policies

5.3         Future Trends

5.3.1        Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.4         Impact Analysis

6.           In-Vitro Diagnostics Market – North America Analysis

6.1         North America In-Vitro Diagnostics Market Revenue Forecasts and Analysis

7.           North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services

7.1         Overview

7.2         In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

7.3         Reagents & Kits

7.3.1        Overview

7.3.2        Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Software & Services

7.5.1        Overview

7.5.2        Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology

8.1         Overview

8.2         In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)

8.3         Immunoassay/Immunochemistry

8.3.1        Overview

8.3.2        Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Clinical Chemistry

8.4.1        Overview

8.4.2        Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Molecular Diagnostics

8.5.1        Overview

8.5.2        Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

8.6         Microbiology

8.6.1        Overview

8.6.2        Microbiology Market Revenue and Forecast to 2027 (US$ Mn)

8.7         Blood Glucose Self-Monitoring

8.7.1        Overview

8.7.2        Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)

8.8         Coagulation and Hemostasis

8.8.1        Overview

8.8.2        Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)

8.9         Haematology

8.9.1        Overview

8.9.2        Haematology Market Revenue and Forecast to 2027 (US$ Mn)

8.10      Urinalysis

8.10.1     Overview

8.10.2     Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)

8.11      Others

8.11.1     Overview

8.11.2     Others Market Revenue and Forecast to 2027 (US$ Mn)

9.           North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application

9.1         Overview

9.2         In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)

9.3         Infectious Diseases

9.3.1        Overview

9.3.2        Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.4         Diabetes

9.4.1        Overview

9.4.2        Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9.5         Oncology

9.5.1        Overview

9.5.2        Oncology Market Revenue and Forecast to 2027 (US$ Mn)

9.6         Cardiology

9.6.1        Overview

9.6.2        Cardiology Market Revenue and Forecast to 2027 (US$ Mn)

9.7         Autoimmune Disease

9.7.1        Overview

9.7.2        Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)

9.8         Nephrology

9.8.1        Overview

9.8.2        Nephrology Market Revenue and Forecast to 2027 (US$ Mn)

9.9         Others

9.9.1        Overview

9.9.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

10.        North America In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user

10.1      Overview

10.2      In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

10.4      Laboratories

10.4.1     Overview

10.4.2     Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.5      Homecare

10.5.1     Overview

10.5.2     Homecare Market Revenue and Forecast to 2027 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecast to 2027 (US$ Mn)

11.        In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1      North America In-Vitro Diagnostics Market Revenue And Forecast To 2027

11.1.1     North America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

11.1.2     US

11.1.2.1       US In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.2.1.1       US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.2.1.2       US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.2.1.3       US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.2.1.4       US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.3     Canada

11.1.3.1       Canada In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.3.1.1       Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.3.1.2       Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.3.1.3       Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.3.1.4       Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.4     Mexico

11.1.4.1       Mexico In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.4.1.1       Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.4.1.2       Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.4.1.3       Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.4.1.4       Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

12.        Impact Of COVID-19 Pandemic on North America In-Vitro Diagnostics Market

12.1      North America: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1      Overview

13.2      Organic Developments Done by The Companies in The Market

13.3      Inorganic Developments Done by The Companies in The Market

14.        COMPANY PROFILES

14.1      Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      F. HOFFMANN-LA ROCHE LTD.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Danaher

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Siemens AG

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Sysmex Corporation

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      THERMO FISHER SCIENTIFIC INC.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      BD

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      bioMerieux SA

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      BIO-RAD LABORATORIES INC.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   QIAGEN

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Key launches 2016: By Roche

Table 2.             US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 3.             US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 4.             US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 5.             US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 6.             Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 7.             Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 8.             Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 9.             Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 10.          Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 11.          Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 12.          Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 13.          Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 14.          Organic Developments Done by The Companies

Table 15.          Inorganic Developments Done by The Companies

Table 16.          Glossary of Terms, In-Vitro Diagnostics Market

 

LIST OF FIGURES

Figure 1.           In-Vitro Diagnostics Market Segmentation

Figure 2.           North America In-Vitro Diagnostics Market Overview

Figure 3.           Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market

Figure 4.           Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           In-Vitro Diagnostics Market - North America PEST Analysis

Figure 7.           In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.           North America In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

Figure 10.        Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

Figure 11.        Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Figure 12.        Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

Figure 13.        In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)

Figure 14.        Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 15.        Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 16.        Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 17.        Microbiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 18.        Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)

Figure 19.        Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 20.        Hematology Market Revenue and Forecast to 2027 (US$ Mn)

Figure 21.        Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 22.        Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.        In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)

Figure 24.        Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.        Diabetes Market Revenue And Forecast To 2027 (US$ Mn)

Figure 26.        Most Prevalent Forms of Cancers Globally, 2018

Figure 27.        Oncology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 28.        Cardiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 29.        Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)

Figure 30.        Nephrology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 31.        Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 32.        In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

Figure 33.        Hospitals Market Revenue And Forecast To 2027 (US$ Mn)

Figure 34.        Laboratories Market Revenue And Forecast To 2027 (US$ Mn)

Figure 35.        Homecare Market Revenue And Forecast To 2027 (US$ Mn)

Figure 36.        Others Market Revenue and Forecast to 2027 (US$ Mn)

Figure 37.        North America In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)

Figure 38.        North America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

Figure 39.        US In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 40.        Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 41.        Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 42.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 43.        Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. F. HOFFMANN-LA ROCHE LTD.
  2. DANAHER
  3. ABBOTT
  4. SIEMENS AG
  5. SYSMEX CORPORATION
  6. THERMO FISHER SCIENTIFIC, INC.
  7. BD
  8. BIOMERIEUX SA
  9. BIO-RAD LABORATORIES, INC.
  10. QIAGEN
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America In-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America In-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the in-vitro diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution 
TIPRE00022125
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing